Abstract
A primary anti-Thy-1 response in mice is under complex genetic control (Zaleski et al. 1986). This control has been shown to involve either class I or class II H-2 molecules depending on the form in which the Thy-1 antigen is presented to a responder. Briefly, when thymocytes from an H-2-compatible donor are used, the cell-bound Thy-1 antigen seems to be presented directly to the responder’s T cells. The latter are believed to require simultaneous stimulation by the carrier-like or helper determinants (Lake and Douglas 1978) or acolytes (Klein and Zaleski 1987). In contrast, when thymocytes from H-2-incompatible donors are used, the cell-free Thy-1 antigen, which is shed from the immunizing thymocytes, appears to be presented by the responder’s macrophages. This presentation most likely involves associative recognition of the Thy-1 antigen and the product of the two complementary Ir-Thy-1 genes (Zaleski and Klein 1978). Recently, it was demonstrated that the product of these genes is identical with a hybrid IA molecule (Quackenbush et al. 1985, Zaleski et al. 1985). The working hypothesis outlined above is based on two crucial observations. First, a good anti-Thy-1 response to the cell-free antigen is demonstrable only in F1 hybrids that express a particular hybrid IA molecule (Quackenbush et al. 1985). Second, in vivo administration of monoclonal antibodies specific for a particular class II molecule inhibits the response to the cell-free, but not to the cell-bound antigen (Zaleski et al. 1985, Quackenbush et al. 1987).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bice, D.E., Gruwell, D.G., Salvagio, J.E. and Hoffmann, E.O. 1972. Suppression of primary immunization by carrageenan - a macrophage toxic agent. Immunol. Communic. 1: 615.
Cantanzaro, P.J., Schwartz, H.J. and Graham, R.C. 1984. Spectrum and possible mechanism of carrageenan cytotoxicity. Am. J. Pathol. 64: 387.
de Duve, C., de Barsy, T., Poole, B., Trovet, A., Tulkens, P. and van Hoff, F. 1974. Lysosomotropic agents. Biochem. Pharmacol. 23: 249.
Fuji, H., Zaleski, M.B. and Milgrom, F. 1971. Immune response to alloantigens of thymus studied in mice with plaque assay. J. Immunol. 106: 56.
Gerson, M.J., D’Arcy Hart, P. and Young, M.R. 1981. Temporal changes of lysosome and phagosome pH during phagolysosome formation in macrophages studied by fluorescence spectroscopy. J. Cell. Biol. 89: 645.
Kappler, J.W., Skidmore, B., White, J. and Marrack, P. 1981. Antigen inducible, H-2 restricted, interleukin-2-producing T-cell hybridomas. J. exp. Med. 153, 1198.
Klein, J. and Zaleski, M.B. 1987. Genetic control of immune responses to Thy-1. In: Thy-1 Immunology, Neurology, and Therapeutic Applications. Â.E. Reif and M. Sclesinger, eds., Marcel Dekker, New York.
Kruisbeek, A.M., Titus, J.A., Stephany, D.A. Gause, B.L. and Longo, D.D. 1985. In vivo treatment with monoclonal anti-IA antibodies.
Disappearance of splenic antigen-presenting cell function concommitant with modulation of splenic cell-surface IA and IE antigens. J. exp. Med. 134: 3605.
Lake, P. and Douglas, T.C. 1978. Recognition and control of helper determinants for cell-surface antigen Thy-1. Nature 275: 430.
Ogasawara, K., Maloy, W.L. and Schwartz, R.H. 1987. Failure to find holes in the T-cell repertoire. Nature 325: 450.
Oppenheim, J.J., Kovacs, E.J., Matsushimo, K. and Durum, S.K. 1986. There is more than one interleukin 1. Immunol. Today 7: 45.
Ozato, K., Epstein, S.L., Hemkart, P., Hansen, T.H. and Sachs, D.H. 1981. Studies on monoclonal antibodies to mouse MHC products. Transpl. Proc. 13: 958.
Pittaluga, G. 1935. Las infermidades del sistema reticulo-endotelial. Calpe, Madrid.
Quackenbush, L.J., Dowjat, W.K. and Zaleski, M.B. 1985. IA mutation affects anti-Thy-1 response in mice. Immunogenetics 21: 617.
Quackenbush, L.J., Dowjat, W.K. and Zaleski, M.B. 1985. Search for IA trans-complementation affecting the anti-Thy-1 response in mice: A final report. Immunol. Inv. 14: 379.
Quackenbush, L.J., Dowjat, W.K., Gorzynski, T.J. and Zaleski, M.B. 1987. Identification of the IA hybrid molecule affecting anti-Thy-1 responsiveness. Transplantation 43: (in press).
Shoemaker, J.P. 1978. Fifty-five percent complete remission of mammary carcinoma in mice with 5-fluorouracil and chloroquine. Cancer Res., 38: 2700.
Unanue, E.R. 1984. Antigen-presenting function of the macrophage. Ann. Rev. Immunol. 2: 395.
Weissman, G., Sessa, G. and Bevans, V. 1967. Effect of DMSO on the stabilization of lysosomes by cortisone and chloroquine in vitro. Ann N.Y. Acad. Sci. 141: 326.
Zaleski, M.B., Gorzynski, T.J., Quackenbush, L.J. and Dowjat, W.K. 1985. In vivo inhibition of anti-Thy-1 response by monoclonal antibody to the IA molecules of the responder. Immunogenetics 22: 673.
Zaleski, M.B., Quackenbush, L.J., Gorzynski, T.J. and Reichner, J.S. 1986. The Ir-Thy-1 concept: Continuing saga. Immunol. Res. 5: 79.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zhou, P., Quackenbush, L.J., Albini, B., Zaleski, M.B. (1987). Macrophage IA Hybrid Molecule as Product of the Ir-Thy-1 Genes. In: David, C.S. (eds) H-2 Antigens. NATO ASI Series, vol 144. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0764-9_29
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0764-9_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0766-3
Online ISBN: 978-1-4757-0764-9
eBook Packages: Springer Book Archive